Skip to content

CNTX - Context Therapeutics Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Context Therapeutics Inc

CNTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CNTXContext Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.62
52-wk low: $0.43
Prev close: $2.23
Mkt cap: $44.8M
Beta: 1.75
P/B: 1.2x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$5.6M

JS
Jim Simons
Q2 2026 13F
$577K
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings came in 50.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $45M

Valuation

P/B1.20

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CNTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $44.79M
Beta: 1.75

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-76.1%

$211K

position

WC

Walleye Capital

Q4 2025 13F

$195K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CNTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.15-50.0%

-$0.10 expected

Next report

What the street expects next

-76.1%

ROA-45.7%

Growth

Beta1.75